Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Chesley Taft & Associates LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)

Article: Future-Ready by Design: AstraZeneca India's HR Playbook for Talent-Led Growth in GCCs - People Matters

An end-to-end attention-based approach for learning on graphs
)
AstraZeneca, BioNTech and CIC back Sortera Bio's £7.5m pre-seed round

The current and emerging immunotherapy paradigm in small-cell lung cancer

The People-First Liver Charter

AstraZeneca CEO suggests cause behind high drug prices

74,997 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Nixon Peabody Trust Co.

GAMMA Investing LLC Buys 573,535 Shares of AstraZeneca PLC (NASDAQ:AZN)

Trixeo Aerosphere approved in the UK as first inhaled respiratory medicine using next-generation propellant with near-zero Global Warming Potential

Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial

Healthy Returns: AstraZeneca, Pfizer, Gilead release cancer drug data
UK Stocks That Might Be Priced Below Estimated Value

Daiichi Sankyo, AstraZeneca Announce Promising DATROWAY Combination Data in NSCLC

AstraZeneca CEO on breast cancer drug trial: This is the future of cancer treatment

AstraZeneca pill helps cut breast cancer progression risk

Experimental AstraZeneca pill helps cut risk of breast cancer progression

Stock market update: Stocks that hit 52-week highs on NSE in today's trade

52 week high stocks: Stock market update: Stocks that hit 52-week lows on NSE in today's trade - The Economic Times

AstraZeneca Reports Encouraging Data For Enhertu As 1st-line Treatment Of HER2+ Breast Cancer

Stocks to watch today, June 2: Vi, Nykaa, IndiGo, Adani Energy, AstraZeneca | Markets News - Business Standard

Stocks to Watch Today: Tata Motors, M&M, Niva Bupa, Alembic Pharma, IRCON, Godrej Properties, Titagarh, AstraZeneca, Genus Power, Nykaa in focus on 2 June

The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development

AstraZeneca, Daiichi announce results from three trials on DATROWAY | Markets Insider

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI | Markets Insider

AstraZeneca announces results from SERENA-6 Phase III trial | Markets Insider

AstraZeneca breast cancer medicine slows disease by over six months

Blood test-guided treatment cuts breast cancer risk | Seymour Telegraph

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer

First pivotal trial to demonstrate clinical value of monitor

AstraZeneca Breast Cancer Pill Slows Disease by Over Six Months

AstraZeneca Says Camizestrant Reduces Risk Of Disease Progression By 56% In SERENA-6 Phase III Trial

AstraZeneca PLC (NASDAQ:AZN) Position Increased by Wealth Enhancement Advisory Services LLC

Toronto Dominion Bank Acquires 9,151 Shares of AstraZeneca PLC (NASDAQ:AZN)

183,548 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

AstraZeneca PLC (NASDAQ:AZN) Short Interest Update

The presence of neutralizing antibodies against omicron subvariants among a vaccinated cohort at one year after the first dose of vaccination in Malaysia

Breast cancer: Pfizer-Arvinas drug beats AstraZeneca's in delaying disease's progression

AZN And Daiichi Sankyo's ENHERTU Shows Significant Survival Benefit In Phase 3 Gastric Cancer Trial

Versant Capital Management Inc Buys 8,562 Shares of AstraZeneca PLC (NASDAQ:AZN)

GTS Securities LLC Sells 41,000 Shares of AstraZeneca PLC (NASDAQ:AZN)

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase II NeoCOAST-2 trial

AstraZeneca Reaches $51 Million Settlement in Pay-for-Delay Suit
AstraZeneca Share Price Today, AstraZeneca Stock Price Live NSE/BSE

AstraZeneca PLC (NASDAQ:AZN) Position Cut by Park National Corp OH

AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution | Markets News - Business Standard

Ostro: Aye To AI For Pharma Marketing, Nay To AI For Pharma Journalism 05/29/2025

Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests

Foreign firms deepen roots, strive for localization - Chinadaily.com.cn

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Danaher, AstraZeneca Form Partnership For Diagnostic Development | Morningstar

AstraZeneca Lung Cancer Treatment: AstraZeneca's Osimertinib Gains Expanded Approval for Lung Cancer Treatment in India, ETPharma

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Integrated Advisors Network LLC

AstraZeneca gets CDSCO nod for lung cancer drug

Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma

AstraZeneca receives CDSCO a pproval for Lung Cancer Drug

8,804 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Brucke Financial Inc.

Regulatory actions for May 28, 2025 | BioWorld

Foreign investment flourishes in Qingdao high-tech zone, boosting economic growth

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Mackenzie Financial Corp Raises Stake in AstraZeneca PLC (NASDAQ:AZN)

Sunbelt Securities Inc. Purchases 3,885 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Given Average Recommendation of "Buy" by Brokerages

AstraZeneca: Imfinzi Gets EU's CHMP Recommendation To Treat Muscle-Invasive Bladder Cancer

Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial

Nvidia and Wallenberg businesses starting AI venture in Sweden

Smile Group appoints former AstraZeneca exec to lead healthtech venture builder

26,048 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Parr Mcknight Wealth Management Group LLC

Two Sigma Advisers LP Acquires Shares of 86,100 AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca (AZN) Receives a Buy from Leerink Partners | Markets Insider

ENHERTU® (trastuzumab deruxtecan) Receives Time-Limited Reimbursement Recommendation from Canada's Drug Agency for Gastric Cancer

Induct AS: AstraZeneca Initiates Commercial Discussions Earlier Than Planned

Principal Street Partners LLC Lowers Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Zacks Research Lowers Earnings Estimates for AstraZeneca

UK court clears the way for Amgen and Samsung to launch biosimilars

Astrazeneca's AZD-6793 arises as a promising therapeutic for COPD | BioWorld

Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27

Other news to note for May 21, 2025 | BioWorld

Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

AstraZeneca's Airsupra asthma treatment shows breakthrough results in trial

AstraZeneca Acquires EsoBiotec To Advance Instant IV-Delivered Cell Therapy For Cancer Treatment

Compugen Ltd. (NASDAQ:CGEN) Q1 2025 Earnings Call Transcript

Texas Bank & Trust Co Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Strategic Wealth Partners Ltd.
AstraZeneca PLC (AZN) Trial: Airsupra Cuts Severe Asthma Risk by 47%

Tezepelumab Cuts Oral Corticosteroid Use in Severe Asthma
Latest news
Show more
Morning Note: ECB Rate Cut Expected; Canada PMI in Focus; EUR/USD, USD/CAD

Morning Note: ECB Rate Cut Expected; Broadcom Earnings; Oil Falls on Supply